Abrar K. Thabit

The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

Christian M Gill, Elif Aktaþ, Wadha Alfouzan et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2021 · 87 citations · Full text

Antibacterial Efficacy of Eravacycline <i>In Vivo</i> against Gram-Positive and Gram-Negative Organisms

Marguerite L. Monogue, Abrar K. Thabit, Yukihiro Hamada et al. · Antimicrobial Agents and Chemotherapy · 2016 · 47 citations · Full text

Antibacterial Agents, Antibacterial Efficacy, Antimicrobial Chemotherapy +23

Pharmacodynamic and pharmacokinetic profiling of delafloxacin in a murine lung model against community-acquired respiratory tract pathogens

Abrar K. Thabit, Jared L. Crandon, David P. Nicolau · International Journal of Antimicrobial Agents · 2016 · 47 citations

Murine Lung Model, Inflammatory Lung Disease, Pharmacokinetic Profiling +9

Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens

Abrar K. Thabit, Khalid Eljaaly, Ayat Zawawi et al. · Biology · 2022 · 40 citations · Full text

Assessment of <i>Clostridium difficile</i> Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin

Seth T. Housman, Abrar K. Thabit, Joseph L. Kuti et al. · Infection Control and Hospital Epidemiology · 2015 · 32 citations